A quarter of a century ago, almost half of global new treatments originated in Europe. Today, the proportion has dropped to 22%. The United States has […]
More process efficiency urged as data shows Finland and Denmark outperform Ireland in drawing research activity Ireland is attracting fewer clinical trials than some European countries […]
Global equity of access to Covid-19 vaccines should be a shared goal, according to the research-based biopharmaceutical industry, with production set to reach 16.3 billion doses by […]
Ireland’s spend on medicines as a proportion of overall health expenditure is below the average of 15 other European countries, according an industry analysis of official […]
Europe-wide survey of EMA-authorised medicines between 2017 and 2020 shows lengthening wait times for Irish patients Germany is over four times faster than Ireland to make […]
91% trust doctors and nurses for accurate information about vaccines Number of ‘vaccine believers’ up 11 points since before the pandemic Almost three in five adults […]
Following the invasion of Ukraine, the research-based biopharmaceutical industry is responding through solidarity, supply and support. We condemn the invasion of Ukraine and stands in solidarity […]
Recent figures showing buoyant tax revenues demonstrate the resilience of the economy during the pandemic. As some of the domestic sector struggles, the economy’s overall performance […]
For immediate release: 15th December, 2021 New medicines supply Agreement to improve patients’ access to innovative new treatments Four-year Agreement reached between international research-based biopharmaceutical industry […]